dr. neelapu on the safety profile of kte-c19 in patients with lymphoma
Published 7 years ago • 169 plays • Length 1:18
Download video MP4
Download video MP3
Similar videos
-
0:53
dr. neelapu on next steps with kte-c19 in lymphoma
-
1:16
dr. neelapu on zuma-1 trial design of kte-c19
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
6:21
sattva s. neelapu, md: encouraging results for car t-cells in refractory dlbcl
-
1:43
dr. neelapu on third-line car t-cell therapy in large b-cell lymphoma
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
1:50
dr. neelapu on potential advantages of allogeneic car t-cell therapy in lymphoma
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
1:09
dr. neelapu discusses efficacy of axi-cel in large b-cell lymphoma
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
1:03
sattva neelapu, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
1:37
sattva neelapu, md, considers the use of axicabtagene ciloleucel with elderly lymphoma patients
-
5:14
axi-cel and future of car t-cell therapy in lymphoma
-
6:03
clinical data for axi-cel in lymphoma
-
1:01
sattva neelapu, md, on the possibility to enhance t-cell proliferation for a higher response rate
-
1:47
meet lymphoma specialist sattva neelapu, m.d.
-
1:33
sattva neelapu, md, on real-world experience & clinical studies examining axicabtagene ciloleucel
-
3:09
sattva neelapu, md, discusses advancements in the management of car t-cell therapy aes
-
1:34
sattva neelapu, md, speculates on the future of first-line car t-cell therapy in lymphoma
Clip.africa.com - Privacy-policy